Rockwell Medical, Inc. (RMTI)
Oxford Ledge is still expanding full research coverage of RMTI. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Rockwell Medical manufactures and distributes hemodialysis concentrates for dialysis clinics and kidney disease patients worldwide.
Source: 10-K (2025-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K 3.03; Amendments to articles or bylaws; Financial statements and exhibits 2026-06-29
- 8-K Shareholder vote results 2026-06-15
- 8-K Delisting / transfer of listing 2026-05-08
- 8-K Regulation FD disclosure; Financial statements and exhibits 2026-05-07
- 10-Q Quarterly financial report (unaudited) 2026-05-07
Source: SEC EDGAR.
Annual results
5 years of annual figures for RMTI, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | $69.3M | -$5.3M | -$0.15 |
| 2024 | $101.5M | -$480,000 | -$0.03 |
| 2023 | $83.6M | -$8.4M | -$0.37 |
| 2022 | $72.8M | -$18.7M | -$1.31 |
| 2021 | $61.9M | -$32.7M | -$3.83 |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
Insider activity
5 recent insider (SEC Form 4) filings on record for RMTI. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open RMTI in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.